Pyridine, 4-(4,8-dimethyl-3,7-nonadienyl)-
Common Name: |
Pyridine, 4-(4,8-dimethyl-3,7-nonadienyl)- |
IUPAC Name: |
4-[(3E)-4,8-dimethylnona-3,7-dienyl]pyridine |
Molecular Formula: |
C16H23N |
SMILES: |
CC(=CCCC(=CCCC1=CC=NC=C1)C)C |
Inchi: |
1S/C16H23N/c1-14(2)6-4-7-15(3)8-5-9-16-10-12-17-13-11-16/h6,8,10-13H,4-5,7,9H2,1-3H3/b15-8+ |
Inchi Key: |
OVJCOXQJBRJIRJ-OVCLIPMQSA-N |
Cas No: |
38462-23-6 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
229.36 |
Mass (g/mol) |
229.183 |
Molar Refractivity |
76.33 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
6 |
Rings |
1 |
TPSA |
12.89 |
Hetero Atoms |
1 |
Heavy Atoms |
17 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
335.00 to 336.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.000107 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.44 |
LogP |
4.707 |
iLOGP |
3.48 |
XLOGP3 |
4.93 |
WLOGP |
4.71 |
MLOGP |
3.54 |
ESOL Log S |
-4.23 |
ESOL Solubility (mg/ml) |
0.013 |
ESOL Solubility (mol/l) |
0 |
ESOL Class: esol_class |
Moderately soluble |
Ali Log S |
-4.94 |
Ali Solubility (mg/ml) |
0 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Moderately soluble |
Silicos-IT LogSw |
-4.99 |
Silicos-IT Solubility (mg/ml) |
0 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Moderately soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-4.20 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.388 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.503 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
1 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |